Full-Time

Organ Health Specialist

Posted on 1/20/2025

Natera

Natera

1,001-5,000 employees

Genetic testing and diagnostics solutions

Biotechnology
Healthcare

Compensation Overview

$185k - $210kAnnually

+ Commission + Car Allowance

Senior

United States

Multiple positions available across different territories in the US.

Category
Healthcare Administration & Support
Medical, Clinical & Veterinary
Required Skills
Sales
Requirements
  • Bachelor's Degree or equivalent educational background
  • At least 6 years of progressive sales experience, preferably in diagnostics, lab-developed tests, or related industries
  • Familiarity with academic medical systems in transplant, nephrology, or specialty medicine
  • Established connections with key opinion leaders (KOLs) in transplant or specialty medicine
  • Training or experience in medicine, biological sciences, or genetics is highly desirable
Responsibilities
  • Exceeding performance goals through effective sales strategies and building lasting client relationships
  • Driving market adoption of Natera’s products, contributing to successful product launches and market expansion
  • Serving as a local expert on Natera’s technology and services, representing the company with professionalism and technical expertise
  • Developing and executing tailored local business plans to achieve sales objectives and maximize available resources
Desired Qualifications
  • Training or experience in medicine, biological sciences, or genetics is highly desirable

Natera focuses on genetic testing and diagnostics, utilizing cell-free DNA (cfDNA) testing to analyze DNA fragments in the blood for cancer detection and organ health assessment. Their technology helps identify minimal traces of cancer in patients and supports transplant patients by monitoring the health of transplanted organs. Natera also offers tests for family planning and hereditary cancer risk, including the Panorama NIPT, which has conducted over 2 million tests. The company stands out by providing specialized testing services and genetic counseling, generating revenue through testing kits and services often reimbursed by insurance.

Company Stage

IPO

Total Funding

$149.9M

Headquarters

Austin, Texas

Founded

2004

Growth & Insights
Headcount

6 month growth

0%

1 year growth

0%

2 year growth

10%
Simplify Jobs

Simplify's Take

What believers are saying

  • Increased adoption of liquid biopsy techniques boosts demand for Natera's cfDNA tests.
  • AI integration enhances accuracy and speed of Natera's cfDNA analysis.
  • Growing personalized medicine trend aligns with Natera's customized genetic tests.

What critics are saying

  • Hindenburg report accuses Natera of deceptive sales practices, risking legal challenges.
  • New Prospera Heart features may face slow adoption by healthcare providers.
  • Fetal RhD NIPT demand may drop post-RhIg shortage, affecting future sales.

What makes Natera unique

  • Natera's Signatera test offers personalized ctDNA analysis for cancer patients.
  • Prospera Heart test uses unique Donor Quantity Score for transplant rejection detection.
  • Panorama NIPT test is a leader in non-invasive prenatal testing with 2 million tests.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Flexible medical plans

Investment options

Time off

Workplace perks